📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1. (2022)

First Author: Heaton BJ

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2022.112999

PubMed Identifier: 35461087

Publication URI: http://europepmc.org/abstract/MED/35461087

Type: Journal Article/Review

Volume: 150

Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ISSN: 0753-3322